ABSTRACT BACKGROUND In patients with coronary artery disease, clinical outcome depends on the extent of reversible
whereas patients with abnormal FFR benefit from revascularization (6) (7) (8) . A meta-analysis suggested a risk continuum between the actual FFR value and clinical outcome, offering mechanistic insight into local plaque progression (9) , yet these data were obtained retrospectively in patients in whom FFR had significantly altered the management strategy.
In the FAME-2 (Fractional Flow Reserve versus Angiography for Multivessel Evaluation-2; NCT01132495) trial (funded by St. Jude Medical), patients were randomized to percutaneous coronary intervention (PCI) or to MT alone when at least 1 coronary stenosis showed an abnormal FFR (7, 8) .
Patients with angiographically significant stenoses that appeared to be hemodynamically nonsignificant were not randomized but treated with MT alone and followed in a registry.
The present report analyzes the outcome of all patients in whom the lesions were assessed with FFR and initially received MT alone, thus describing the natural history of coronary atherosclerosis from a coronary hemodynamic perspective.
METHODS
PATIENTS. The study design and the results of the FAME-2 trial have been previously reported (7) .
In short, the FAME-2 trial randomized consecutive patients with stable angina and angiographically Barbato et al. reported according to the main FAME-2 trial (7) in the following strata of diameter stenosis: <50%, 50% to 69%, 70% to 90%, and >90%. We excluded vessels with chronic total occlusions from our analysis (n ¼ 28), as FFR was not measured in these vessels, and an arbitrary value of 0.50 was assigned according to the FAME-2 trial protocol.
ENDPOINTS. This is a pre-specified subanalysis of the FAME-2 study. The primary endpoint is major adverse cardiovascular event (MACE) at 2 years, defined as the composite of cardiovascular (CV) death, target vesselrelated myocardial infarction (MI), and ischemiadriven target vessel revascularization (TVR) (both urgent and nonurgent). All outcomes were previously adjudicated by an independent clinical events committee whose members were unaware of the treatment assignments. All the narratives of the patients experiencing an event at follow-up were blindly reviewed and the event was unequivocally assigned to the culprit vessel in case of MI and ischemia-driven TVR.
When the identification of the culprit vessel was not Values are n (%) unless otherwise indicated. *For 6 lesions in patients without major adverse cardiovascular events (MACE), and 3 lesions in patients with MACE, data on lesion type was unavailable.
BMI ¼ body mass index; CI ¼ confidence interval; CCS ¼ Canadian Cardiovascular Society; DS ¼ diameter stenosis; EF ¼ ejection fraction; HR ¼ hazard ratio; ID ¼ insulin dependent; LAD ¼ left anterior descending artery; LCx ¼ left circumflex artery; LMCA ¼ left main coronary artery; MI ¼ myocardial infarction; MVD ¼ multivessel disease; PCI ¼ percutaneous coronary intervention; RCA ¼ right coronary artery.
Barbato et al. Table 1 and Online Table 1 . Overall, the patients had common risk factors for coronary artery disease, with up to two-thirds of them presenting with multivessel disease (429 of 607). There were no significant differences between patients with or without MACE, with the exception of CCS angina class $3 that was more frequent in those patients experiencing an event during follow-up.
Angiographic characteristics of the 1,029 stenotic vessels included are reported in Table 1 . Overall, the stenosis was commonly located in the left anterior descending coronary artery (in about 50% of the cases). A majority of the lesions were in the intermediate range of 50% to 69% diameter stenosis, and of moderate complexity (Online Table 2 ). There were no significant differences in terms of vessel location Barbato et al. CLINICAL ENDPOINTS. Clinical follow-up was available in all patients with a mean duration of 23 AE 2 months. MT at 2 years was available in 582 patients (96%) and was not different between patients with or without MACE (Online Table 3 ). The cumulative incidence of MACE was significantly increased also with increasing % diameter stenosis severity and increasing stenosis complexity as expressed by the lesion type (Online Figure 2) . Nevertheless, only lesion complexity remained significant after adjusting for potential confounders ( Table 3) . In Q ¼ quartile; other abbreviations as in Table 1 .
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